Form 4: Channel Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Ezra M Friedberg, a Director of Channel Therapeutics Corp, sold 558 shares of common stock on October 2, 2026 for $20.72 per share.
Summary
- Open-market sale: disposed of 558 Common Stock at $20.72 ($11,560) on October 2, 2026; holds 80,484 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $11,560 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Ezra M Friedberg — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Common Stock | 558 | $21 | $11.6K | 80,484 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (558 shares) |
Keywords
insider transaction, Form 4, PTHS, Pelthos Therapeutics Inc., bearish, Ezra M Friedberg
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.